Skip to main content

Pharma giant acquires Phoenix-based startup developing eye treatments

The Phoenix firm's technology has shown early clinical success in treating an eye disorder.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.